JP2008546716A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008546716A5 JP2008546716A5 JP2008517215A JP2008517215A JP2008546716A5 JP 2008546716 A5 JP2008546716 A5 JP 2008546716A5 JP 2008517215 A JP2008517215 A JP 2008517215A JP 2008517215 A JP2008517215 A JP 2008517215A JP 2008546716 A5 JP2008546716 A5 JP 2008546716A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- antigen
- amino acid
- binding fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69185005P | 2005-06-17 | 2005-06-17 | |
| PCT/US2006/023821 WO2006138721A1 (en) | 2005-06-17 | 2006-06-16 | Anti-gfralpha3 antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008546716A JP2008546716A (ja) | 2008-12-25 |
| JP2008546716A5 true JP2008546716A5 (https=) | 2009-07-30 |
Family
ID=37570787
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008517215A Withdrawn JP2008546716A (ja) | 2005-06-17 | 2006-06-16 | 抗ＧＦＲα３抗体 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20090202562A1 (https=) |
| EP (1) | EP1896047A4 (https=) |
| JP (1) | JP2008546716A (https=) |
| CA (1) | CA2612417A1 (https=) |
| WO (1) | WO2006138721A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO3462B1 (ar) * | 2012-08-22 | 2020-07-05 | Regeneron Pharma | أجسام مضادة بشرية تجاه gfr?3 وطرق لاستخدامها |
| US11542332B2 (en) | 2016-03-26 | 2023-01-03 | Bioatla, Inc. | Anti-CTLA4 antibodies, antibody fragments, their immunoconjugates and uses thereof |
| MX2021012335A (es) * | 2019-04-10 | 2021-11-12 | Regeneron Pharma | Anticuerpos humanos que se unen a ret y metodos de uso de los mismos. |
| EP4406972A4 (en) * | 2021-09-24 | 2025-12-31 | Daegu Gyeongbuk Inst Science & Tech | GFRAL ANTAGONIST ANTIBODY WITH IMPROVED AFINITY, AND ITS USE |
| KR102864956B1 (ko) * | 2021-09-24 | 2025-09-30 | 재단법인대구경북과학기술원 | 친화도가 개선된 gfral 길항 항체 및 이의 용도 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6677135B1 (en) * | 1996-05-08 | 2004-01-13 | Biogen, Inc. | Ret ligand (RetL) for stimulating neutral and renal growth |
| EP0962467A4 (en) * | 1996-09-26 | 2002-10-30 | Chugai Pharmaceutical Co Ltd | Antibody against human parathormone related peptides |
| EP1156062A1 (en) * | 2000-05-12 | 2001-11-21 | GPC Biotech AG | Immunomodulatory human MHC class II antigen-binding peptides/proteins |
-
2006
- 2006-06-16 US US11/917,676 patent/US20090202562A1/en not_active Abandoned
- 2006-06-16 CA CA002612417A patent/CA2612417A1/en not_active Abandoned
- 2006-06-16 EP EP06785113A patent/EP1896047A4/en not_active Withdrawn
- 2006-06-16 WO PCT/US2006/023821 patent/WO2006138721A1/en not_active Ceased
- 2006-06-16 JP JP2008517215A patent/JP2008546716A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230287119A1 (en) | Anti-cd3 antibody and molecules comprising the antibody | |
| HRP20191462T1 (hr) | Antitijela usmjerena protiv her-3 i njihove uporabe | |
| JP2015535828A5 (https=) | ||
| JP2017048240A5 (https=) | ||
| RU2017114341A (ru) | Антитела к pd-l1, связывающие pd-l1 собаки | |
| JP2021508469A5 (https=) | ||
| HRP20201375T1 (hr) | ANTI-BCMA ANTITIJELA, BISPECIFIČNI ANTIGEN VEŽUĆE MOLEKULE KOJE SE VEŽU ZA BCMA i CD3, I NJIHOVE UPOTREBE | |
| JP2017505125A5 (https=) | ||
| NO20066052L (no) | Anti-CD3 antistoffer og fremgangsmater for anvendelse derav | |
| JP2021525546A5 (https=) | ||
| JP2009225799A5 (https=) | ||
| CA2818635C (en) | Antibodies selective for cells presenting erbb2 at high density | |
| JP2018520657A5 (https=) | ||
| IL273196B2 (en) | Claudin6 antibodies and methods of treating cancer | |
| JP2013198490A5 (https=) | ||
| JP2013506428A5 (https=) | ||
| JP2019535254A5 (ja) | 抗ｐｄ−ｌ１抗体および変異型 | |
| FI3322727T3 (fi) | Humanisoituja tai kimeerisiä CD3-vasta-aineita | |
| JP2018503380A5 (https=) | ||
| JP2012525829A5 (https=) | ||
| JP2010535205A5 (https=) | ||
| RU2015126533A (ru) | Анти-cd47 антитела и способы их применения | |
| JP2011517447A5 (https=) | ||
| JP2014526898A5 (https=) | ||
| RU2010129045A (ru) | Связывающие молекулы к рецептору ох40 человека |